電気治療/生体電気医療の世界市場予測(~2029):製品別、種類別、用途別

■ 英語タイトル:Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) - Global Forecast to 2029

調査会社MarketsandMarkets社が発行したリサーチレポート(データ管理コード:MD4358-24)■ 発行会社/調査会社:MarketsandMarkets
■ 商品コード:MD4358-24
■ 発行日:2024年3月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:382
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[電気治療/生体電気医療の世界市場予測(~2029):製品別、種類別、用途別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

“電気医療/生体電気医療の世界市場は、2024年239億米ドルから2029年336億米ドルまで、予測期間中に年平均成長率7.0%で成長すると予測”この成長は主に、心臓リズム管理(CRM)機器に関する研究への投資や資金提供の増加、神経疾患に対する政府の支援や資金提供の増加、神経疾患や心血管疾患の有病率の上昇につながる高齢者人口の増加など、いくつかの要因によってもたらされています。しかし、電気医療機器のコストが高く、多額の設備投資が必要であることが、市場の成長を妨げています。

“予測期間中、製品別市場で最も高い成長率を占めたのは網膜インプラントセグメント”
電気医療/生体電気医療市場は製品別に、心臓ペースメーカー&植え込み型除細動器、神経調節器、人工内耳、網膜インプラントに区分されます。2022年には、網膜インプラント分野が電気製剤市場で最も高い成長率を占めました。網膜インプラントの主な原動力は、網膜色素変性症や加齢黄斑変性症などの網膜変性疾患患者の視力を回復させる可能性があることです。

“非侵襲的電気医療機器セグメントは予測期間中に最も高い収益成長率を経験すると予測”
電気治療/生体電気医療市場は、植え込み型電気治療器と非侵襲型電気治療器の2つのセグメントに分けられます。2022年には、非侵襲性電気治療機器セグメントが最も高い成長率を経験しました。これらの機器は外科的な埋め込みを必要とせず、電界や磁界を利用して体表面の神経や筋肉を刺激します。使いやすく、費用対効果が高く、感染リスクも低いです。非侵襲的電気治療薬は、慢性疼痛、神経障害、代謝障害の治療にますます使用されるようになっています。非侵襲性電気治療/生体電気医療の技術的進歩は、医療費の増加や慢性疾患の有病率の上昇とともに、予測期間における非侵襲性機器セグメントの成長を促進すると予測されています。

“アジア太平洋: 電気治療/生体電気医療市場において最も成長著しい地域”
世界の電気医療/生体電気医療市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカに分けられます。アジア太平洋地域は予測期間中に最も高いCAGRを記録する見込みです。この成長は、医療費の増加、医薬研究費の増加、疾病の早期発見に関する意識を高めるための政府の取り組み、APAC各国の農村部への民間病院の進出、同地域の高成長市場の存在などの要因によるものです。

本レポートのために実施した一次インタビューは以下のように分類されます:
- 企業タイプ別 ティア1:28%、ティア2:42%、ティア3:30%
- 役職別 Cレベル - 30%、Dレベル - 34%、その他 - 36%
- 地域別 北米:46%、ヨーロッパ:25%、アジア太平洋地域:18%、その他の地域:11%

レポート掲載企業リスト
• Medtronic plc (Ireland)
• Boston Scientific Corporation (US)
• Abbott Laboratories, Inc. (US)
• Cochlear Ltd. (Australia)
• LivaNova PLC (UK)
• MicroPort Scientific Corporation (China)
• Sonova Group (Switzerland)
• Nevro Corp. (US)
• Axonics Modulation Technologies, Inc. (US)
• Neuronetics, Inc. (US)
• ElectroCore, Inc. (US)
• NeuroPace, Inc. (US)
• BIOTRONIK (Germany)
• Medico S.p.A. (Italy)
• Nurotron Biotechnology Co. Ltd. (US)
• MED-EL (Austria)
• Aleva Neurotherapeutics SA (Switzerland)
• NeuroSigma, Inc. (US)
• BioWave Corporation (US)
• Soterix Medical Inc. (US)
• Bioinduction (Amber Therapeutics) (UK)
• GiMer Medical (Taiwan)
• Cefaly (Belgium)
• BioControl Medical (Israel)
• tVNS Technologies GmbH (Germany)

調査範囲
本調査レポートは、電気治療/生体電気医療市場を製品、タイプ、用途、地域別に分類しています。電気治療/生体電気医療市場の成長に影響を与える促進要因、阻害要因、課題、機会などの主要要因に関する詳細情報を網羅しています。主要な産業プレイヤーを詳細に分析し、その事業概要、ソリューション、主要戦略、契約、パートナーシップ、協定、新製品の発売、M&A、電気治療/生体電気医療市場に関連する最近の動向に関する洞察を提供します。本レポートでは、医療用電解質市場のエコシステムにおける今後の新興企業の競争分析もカバーしています。

レポート購入の主な利点
本レポートは、電気治療/生体電気医療市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します:
- 電気治療/生体電気医療市場の成長に影響を与える主な促進要因、阻害要因、機会、課題の分析
- 製品開発/イノベーション: 市場における今後の技術、研究開発活動、新製品発売に関する詳細な洞察。
- 市場開発: 有利な市場に関する包括的な情報 - 本レポートでは、様々な地域における電気製剤市場を分析しています。
- 市場の多様化: 市場における新製品、未開拓の地域、最近の開発、投資に関する詳細な情報。
- 競争力の評価: Medtronic plc(アイルランド)、Boston Scientific Corporation(米国)、Abbott Laboratories, Inc. (オーストラリア)などの主要企業の市場ランキングや成長戦略、製品提供を詳細に評価します。

1 はじめに
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 電気治療/生体電気医療市場:製品別
7 電気治療/生体電気医療市場:種類別
8 電気治療/生体電気医療市場:用途別
9 電気治療/生体電気医療市場:地域別
10 競争状況
11 企業プロファイル
12 付録

*** レポート目次(コンテンツ)***

1 INTRODUCTION 53
1.1 STUDY OBJECTIVES 53
1.2 MARKET DEFINITION 53
1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY 54
1.3 STUDY SCOPE 54
FIGURE 1 ELECTROCEUTICALS MARKET SEGMENTATION 54
1.3.1 GEOGRAPHIC SCOPE 55
1.3.2 YEARS CONSIDERED 55
1.4 CURRENCY 56
1.5 LIMITATIONS 56
1.6 STAKEHOLDERS 56
1.7 SUMMARY OF CHANGES 57
1.7.1 RECESSION IMPACT 57
2 RESEARCH METHODOLOGY 58
2.1 RESEARCH DATA 58
FIGURE 2 RESEARCH DESIGN 58
2.1.1 SECONDARY DATA 59
2.1.1.1 Key data from secondary sources 59
2.1.2 PRIMARY DATA 60
2.1.2.1 Key data from primary sources 61
2.1.2.2 Key industry insights 62
TABLE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 62
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 63
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION 63
2.2 MARKET SIZE ESTIMATION 64
2.2.1 BOTTOM-UP APPROACH 64
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (COMPANY REVENUE ESTIMATION APPROACH) 64
FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (SEGMENTAL REVENUE ESTIMATION APPROACH) 65
FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 66
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 66
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 67
FIGURE 9 DATA TRIANGULATION METHODOLOGY 67
2.4 MARKET SHARE ANALYSIS 68
2.5 ASSUMPTIONS 68
2.6 RISK ASSESSMENT 68
TABLE 2 RISK ASSESSMENT: ELECTROCEUTICALS MARKET 68
2.7 LIMITATIONS 69
2.7.1 METHODOLOGY-RELATED LIMITATIONS 69
2.7.2 SCOPE-RELATED LIMITATIONS 69
2.8 IMPACT OF RECESSION ON ELECTROCEUTICALS MARKET 69
3 EXECUTIVE SUMMARY 70
FIGURE 10 ELECTROCEUTICALS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 70
FIGURE 11 ELECTROCEUTICALS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 71
FIGURE 12 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 71
FIGURE 13 ELECTROCEUTICALS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 72
4 PREMIUM INSIGHTS 73
4.1 ELECTROCEUTICALS MARKET OVERVIEW 73
FIGURE 14 RISING PREVALENCE OF NEUROLOGICAL AND CARDIOVASCULAR DISORDERS TO DRIVE MARKET 73
4.2 ELECTROCEUTICALS MARKET SHARE, BY PRODUCT, 2024 VS. 2029 74
FIGURE 15 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS WILL CONTINUE TO DOMINATE MARKET IN 2029 74
4.3 ELECTROCEUTICALS MARKET SHARE, BY TYPE, 2024 VS. 2029 74
FIGURE 16 IMPLANTABLE ELECTROCEUTICAL DEVICES TO DOMINATE MARKET IN 2024 74
4.4 ELECTROCEUTICALS MARKET SHARE FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029 75
FIGURE 17 ARRHYTHMIA SEGMENT TO DOMINATE MARKET IN 2029 75
4.5 ELECTROCEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 75
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN ELECTROCEUTICALS MARKET DURING FORECAST PERIOD 75
5 MARKET OVERVIEW 76
5.1 INTRODUCTION 76
5.2 MARKET DYNAMICS 76
FIGURE 19 ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 76
5.2.1 DRIVERS 77
5.2.1.1 Rising geriatric population and subsequent growth in prevalence of neurological and cardiovascular disorders 77
5.2.1.2 Rising government support and funding for neurological disorders 78
5.2.1.3 Increasing investments and funding for research on CRM devices 78
5.2.1.4 Increasing focus on development of advanced neuromodulation and cardiac devices 79
5.2.1.5 Increasing collaborations among device manufacturers, healthcare providers, and research institutes to develop neuromodulation and cardiac devices 79
5.2.1.6 Availability of reimbursements for neuromodulation, cardiac devices, and cochlear implants 80
5.2.1.7 Growing prevalence of hearing loss and increasing adoption of smart hearing aids 80
5.2.2 RESTRAINTS 81
5.2.2.1 High cost of electroceutical devices 81
5.2.2.2 Preference for drug therapies over neuromodulation and cardiac products 81
5.2.2.3 Adverse effects and complications associated with neuromodulation, cardiac devices, and cochlear implants 81
TABLE 3 POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES 82
5.2.3 OPPORTUNITIES 82
5.2.3.1 Emerging markets 82
5.2.3.2 Development of ICDs and MRI-compatible ICDs and CRT-Ds 83
5.2.3.3 Integration with digital health platforms 83
5.2.4 CHALLENGES 84
5.2.4.1 Dearth of trained professionals 84
5.2.4.2 Challenges associated with battery life and device replacement 84
5.2.4.3 Complexity and infection issues related to electroceutical devices 85
5.2.5 TRENDS 85
5.2.5.1 Role of artificial intelligence (AI) in electroceutical devices 85
5.2.5.2 Wearable and portable electroceuticals 86
5.3 PRICING ANALYSIS 86
TABLE 4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022) 86
TABLE 5 AVERAGE SELLING PRICE TREND FOR NEUROMODULATION DEVICES AND PROCEDURES, BY REGION (2022) 86
5.4 VALUE CHAIN ANALYSIS 87
FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 87
5.5 SUPPLY CHAIN ANALYSIS 88
FIGURE 21 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES 89
5.6 ECOSYSTEM ANALYSIS OF ELECTROCEUTICALS MARKET 89
FIGURE 22 ELECTROCEUTICALS MARKET: ECOSYSTEM ANALYSIS 89
5.6.1 ROLE IN ECOSYSTEM 90
TABLE 6 ELECTROCEUTICALS MARKET: ROLE IN ECOSYSTEM 90
5.6.2 KEY PLAYERS IN ELECTROCEUTICALS MARKET 90
FIGURE 23 ELECTROCEUTICALS MARKET: KEY PLAYERS 90
5.7 PORTER’S FIVE FORCES ANALYSIS 91
TABLE 7 ELECTROCEUTICALS MARKET: PORTER’S FIVE FORCES ANALYSIS 91
5.7.1 THREAT OF NEW ENTRANTS 91
5.7.2 INTENSITY OF COMPETITIVE RIVALRY 91
5.7.3 BARGAINING POWER OF BUYERS 91
5.7.4 BARGAINING POWER OF SUPPLIERS 91
5.7.5 THREAT OF SUBSTITUTES 92
5.8 REGULATORY LANDSCAPE 92
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 8 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING ELECTROCEUTICALS MARKET 92
5.8.2 NORTH AMERICA 93
5.8.2.1 US 93
TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION 93
TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 93
5.8.2.2 Canada 94
TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 94
5.8.3 EUROPE 94
5.8.4 ASIA PACIFIC 94
5.8.4.1 China 94
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 95
5.8.4.2 Japan 95
5.8.4.3 India 95
5.9 TECHNOLOGY ANALYSIS 96
5.10 TRADE ANALYSIS 97
5.10.1 IMPORT SCENARIO FOR PACEMAKERS 97
TABLE 13 IMPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018–2022 (USD MILLION) 97
5.10.2 EXPORT SCENARIO FOR PACEMAKERS 98
TABLE 14 EXPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018–2022 (USD MILLION) 98
5.10.3 IMPORT SCENARIO FOR COMPLIANT PRODUCTS 98
TABLE 15 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION) 98
5.10.4 EXPORT SCENARIO FOR COMPLIANT PRODUCTS 99
TABLE 16 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION) 99
5.11 PATENT ANALYSIS 99
FIGURE 24 ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF CARDIAC PACEMAKERS 99
FIGURE 25 ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF NEUROMODULATION PRODUCTS 100
5.12 KEY CONFERENCES AND EVENTS 100
TABLE 17 LIST OF CONFERENCES & EVENTS, 2024–2025 100
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 102
FIGURE 26 REVENUE SHIFT FOR ELECTROCEUTICALS MARKET 102
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 103
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 103
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 103
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 103
5.14.2 BUYING CRITERIA 103
FIGURE 28 KEY BUYING CRITERIA FOR HOSPITALS 103
6 ELECTROCEUTICALS MARKET, BY PRODUCT 104
6.1 INTRODUCTION 105
TABLE 19 ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 105
6.2 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 105
6.2.1 INTRODUCTION OF LEADLESS AND MRI-SAFE PACEMAKERS & DEFIBRILLATORS TO BOOST MARKET GROWTH 105
TABLE 20 KEY PRODUCTS IN CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET 107
TABLE 21 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 108
TABLE 22 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 108
TABLE 23 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 109
TABLE 24 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 109
TABLE 25 MIDDLE EAST & AFRICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 110
6.3 COCHLEAR IMPLANTS 110
6.3.1 INCREASING PREVALENCE OF HEARING LOSS TO DRIVE DEMAND 110
TABLE 26 KEY PRODUCTS IN COCHLEAR IMPLANTS MARKET 111
TABLE 27 COCHLEAR IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION) 111
TABLE 28 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 112
TABLE 29 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 112
TABLE 30 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 113
TABLE 31 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION) 113
6.4 NEUROMODULATORS 113
TABLE 32 NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 114
TABLE 33 NEUROMODULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 114
TABLE 34 NORTH AMERICA: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 115
TABLE 35 EUROPE: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 115
TABLE 36 ASIA PACIFIC: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 116
TABLE 37 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 116
6.4.1 SPINAL CORD STIMULATORS 116
6.4.1.1 Growing incidence of spinal cord injuries to support market growth 116
TABLE 38 KEY SPINAL CORD STIMULATOR DEVICES AVAILABLE IN MARKET 118
TABLE 39 SPINAL CORD STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 118
TABLE 40 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 119
TABLE 41 EUROPE: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 119
TABLE 42 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 120
TABLE 43 MIDDLE EAST & AFRICA: SPINAL CORD STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 120
6.4.2 DEEP BRAIN STIMULATORS 120
6.4.2.1 Widely used to control debilitating symptoms caused by movement and neurological disorders 120
TABLE 44 KEY DEEP BRAIN STIMULATOR DEVICES AVAILABLE IN MARKET 121
TABLE 45 DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 122
TABLE 46 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 122
TABLE 47 EUROPE: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 123
TABLE 48 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 123
TABLE 49 MIDDLE EAST & AFRICA: DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 124
6.4.3 VAGUS NERVE STIMULATORS 124
6.4.3.1 High incidence of epilepsy to drive market 124
TABLE 50 KEY VAGUS NERVE STIMULATOR DEVICES AVAILABLE IN MARKET 124
TABLE 51 VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 125
TABLE 52 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 125
TABLE 53 EUROPE: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 126
TABLE 54 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 126
TABLE 55 MIDDLE EAST & AFRICA: VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 127
6.4.4 SACRAL NERVE STIMULATORS 127
6.4.4.1 Widening scope of sacral nerve stimulation to drive growth 127
TABLE 56 KEY SACRAL NERVE STIMULATOR DEVICES AVAILABLE IN MARKET 128
TABLE 57 SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 128
TABLE 58 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 128
TABLE 59 EUROPE: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 129
TABLE 60 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 129
TABLE 61 MIDDLE EAST & AFRICA: SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 130
6.4.5 GASTRIC ELECTRICAL STIMULATORS 130
6.4.5.1 Growing number of people suffering from severe GERD and gastroparesis to fuel market growth 130
TABLE 62 GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 131
TABLE 63 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 131
TABLE 64 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 132
TABLE 65 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 132
TABLE 66 MIDDLE EAST & AFRICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 133
6.4.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS 133
6.4.6.1 Extensive use in healthcare, low cost, and ease of use to favor market growth 133
TABLE 67 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 134
TABLE 68 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 134
TABLE 69 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 135
TABLE 70 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 135
TABLE 71 MIDDLE EAST & AFRICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 136
6.4.7 TRANSCRANIAL MAGNETIC STIMULATORS 136
6.4.7.1 Minimal patient discomfort associated with TMS to support demand 136
TABLE 72 TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 137
TABLE 73 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 137
TABLE 74 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 138
TABLE 75 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 138
TABLE 76 MIDDLE EAST & AFRICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 139
6.4.8 RESPIRATORY ELECTRICAL STIMULATORS 139
6.4.8.1 Increasing incidence of spinal cord injuries to drive market 139
TABLE 77 RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 140
TABLE 78 NORTH AMERICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 140
TABLE 79 EUROPE: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 141
TABLE 80 ASIA PACIFIC: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 141
TABLE 81 MIDDLE EAST & AFRICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 142
6.4.9 TRIGEMINAL NERVE STIMULATORS 142
6.4.9.1 High treatment efficacy to fuel market growth 142
TABLE 82 TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 142
TABLE 83 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 143
TABLE 84 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 143
TABLE 85 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 144
TABLE 86 MIDDLE EAST & AFRICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 144
6.4.10 RESPONSIVE NEUROSTIMULATORS 144
6.4.10.1 Targeted and personalized treatment to fuel market growth 144
TABLE 87 RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 145
TABLE 88 NORTH AMERICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 145
TABLE 89 EUROPE: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 146
TABLE 90 ASIA PACIFIC: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 146
TABLE 91 MIDDLE EAST & AFRICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 147
6.5 RETINAL IMPLANTS 147
6.5.1 GROWING NUMBER OF RETINITIS PIGMENTOSA CASES TO SUPPORT MARKET GROWTH 147
TABLE 92 RETINAL IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION) 148
TABLE 93 NORTH AMERICA: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 148
TABLE 94 EUROPE: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 149
TABLE 95 ASIA PACIFIC: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 149
TABLE 96 MIDDLE EAST & AFRICA: RETINAL IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION) 150
7 ELECTROCEUTICALS MARKET, BY TYPE 151
7.1 INTRODUCTION 152
TABLE 97 ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 152
7.2 IMPLANTABLE ELECTROCEUTICAL DEVICES 152
7.2.1 LONG-TERM COST SAVINGS TO DRIVE MARKET 152
TABLE 98 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION) 154
TABLE 99 NORTH AMERICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 154
TABLE 100 EUROPE: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 155
TABLE 101 ASIA PACIFIC: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 155
TABLE 102 MIDDLE EAST & AFRICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION) 156
7.3 NONINVASIVE ELECTROCEUTICAL DEVICES 156
7.3.1 EXTENSIVE USE IN HEALTHCARE, EASE OF USE, AND LOW COST TO SUPPORT MARKET GROWTH 156
TABLE 103 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION) 157
TABLE 104 NORTH AMERICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 158
TABLE 105 EUROPE: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 158
TABLE 106 ASIA PACIFIC: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 159
TABLE 107 MIDDLE EAST & AFRICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION) 159
8 ELECTROCEUTICALS MARKET, BY APPLICATION 160
8.1 INTRODUCTION 161
8.2 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), BY APPLICATION 161
TABLE 108 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 161
8.2.1 ARRHYTHMIA 161
8.2.1.1 Increasing prevalence of arrhythmia to support market growth 161
TABLE 109 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY REGION, 2021–2029 (USD MILLION) 162
TABLE 110 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION) 162
TABLE 111 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION) 163
TABLE 112 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION) 163
8.2.2 HEART FAILURE 164
8.2.2.1 Rising prevalence of heart-related conditions in older individuals to drive growth 164
TABLE 113 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY REGION, 2021–2029 (USD MILLION) 164
TABLE 114 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION) 165
TABLE 115 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION) 165
TABLE 116 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION) 166
8.2.3 OTHER CARDIAC PACEMAKER & ICD APPLICATIONS 166
TABLE 117 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION) 167
TABLE 118 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 167
TABLE 119 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 168
TABLE 120 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 168
8.3 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION 169
TABLE 121 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 169
8.3.1 CHRONIC PAIN 169
8.3.1.1 High incidence of chronic pain to support market growth 169
TABLE 122 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2021–2029 (USD MILLION) 170
TABLE 123 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION) 170
TABLE 124 EUROPE: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION) 171
TABLE 125 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION) 171
8.3.2 FAILED BACK SURGERY SYNDROME 172
8.3.2.1 Increasing incidence of FBSS to drive demand 172
TABLE 126 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2021–2029 (USD MILLION) 172
TABLE 127 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION) 173
TABLE 128 EUROPE: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION) 173
TABLE 129 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION) 174
8.3.3 ISCHEMIA 174
8.3.3.1 High effectiveness of neuromodulation for ischemia treatment to propel market 174
TABLE 130 SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY REGION, 2021–2029 (USD MILLION) 175
TABLE 131 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION) 175
TABLE 132 EUROPE: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION) 176
TABLE 133 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION) 176
8.4 ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION 177
TABLE 134 ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 177
8.4.1 PARKINSON’S DISEASE 177
8.4.1.1 Rising incidence of Parkinson’s disease and growing R&D to drive market 177
TABLE 135 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY REGION, 2021–2029 (USD MILLION) 178
TABLE 136 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION) 178
TABLE 137 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION) 179
TABLE 138 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION) 179
8.4.2 TREMORS 180
8.4.2.1 High efficacy of DBS in treating tremors to drive market 180
TABLE 139 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2021–2029 (USD MILLION) 180
TABLE 140 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION) 180
TABLE 141 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION) 181
TABLE 142 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION) 181
8.4.3 DEPRESSION 182
8.4.3.1 Rising research and clinical studies related to depression treatment to propel market 182
TABLE 143 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021–2029 (USD MILLION) 182
TABLE 144 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION) 183
TABLE 145 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION) 183
TABLE 146 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION) 184
8.4.4 OTHER DBS APPLICATIONS 184
TABLE 147 DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION) 185
TABLE 148 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 185
TABLE 149 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 186
TABLE 150 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 186
8.5 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION 187
TABLE 151 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 187
8.5.1 URINE INCONTINENCE 187
8.5.1.1 High incidence of urine incontinence to offer growth opportunities for market players 187
TABLE 152 SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY REGION, 2021–2029 (USD MILLION) 188
TABLE 153 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION) 188
TABLE 154 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION) 189
TABLE 155 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION) 189
8.5.2 FECAL INCONTINENCE 190
8.5.2.1 Reduced symptom recurrence with use of SNS to drive demand 190
TABLE 156 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2021–2029 (USD MILLION) 190
TABLE 157 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION) 190
TABLE 158 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION) 191
TABLE 159 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION) 191
8.6 ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION 192
TABLE 160 ELECTROCEUTICALS MARKET FOR VAGUS NERVE SIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 192
8.6.1 EPILEPSY 192
8.6.1.1 Advantages associated with VNS in epilepsy treatment to propel market 192
TABLE 161 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2021–2029 (USD MILLION) 192
TABLE 162 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION) 193
TABLE 163 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION) 193
TABLE 164 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION) 194
8.6.2 OTHER VNS APPLICATIONS 194
TABLE 165 VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION) 194
TABLE 166 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 195
TABLE 167 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 195
TABLE 168 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 196
8.7 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION 196
TABLE 169 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 196
8.7.1 GASTROPARESIS 197
8.7.1.1 Reduced hospitalization time associated with GES treatment to drive market 197
TABLE 170 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2021–2029 (USD MILLION) 197
TABLE 171 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION) 197
TABLE 172 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION) 198
TABLE 173 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION) 198
8.7.2 OBESITY 199
8.7.2.1 High prevalence of obesity and risks associated with gastric bypass to propel market 199
TABLE 174 GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY REGION, 2021–2029 (USD MILLION) 199
TABLE 175 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION) 199
TABLE 176 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION) 200
TABLE 177 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION) 200

8.8 ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION 201
TABLE 178 ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 201
8.8.1 TREATMENT-RESISTANT DEPRESSION 201
8.8.1.1 High prevalence of depression to drive market 201
TABLE 179 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2021–2029 (USD MILLION) 201
TABLE 180 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION) 202
TABLE 181 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION) 202
TABLE 182 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION) 203
8.8.2 OTHER TENS APPLICATIONS 203
TABLE 183 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION) 203
TABLE 184 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, 2021–2029 (USD MILLION) 204
TABLE 185 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 204
TABLE 186 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 205
8.9 ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION 205
TABLE 187 ELECTROCEUTICALS MARKET FOR TR
9 ELECTROCEUTICALS MARKET, BY REGION 217
9.1 INTRODUCTION 218
TABLE 206 ELECTROCEUTICALS MARKET, BY REGION, 2021–2029 (USD MILLION) 218
9.2 NORTH AMERICA 218
FIGURE 29 NORTH AMERICA: ELECTROCEUTICALS MARKET SNAPSHOT 219
TABLE 207 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 220
TABLE 208 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 220
TABLE 209 NORTH AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 221
TABLE 210 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 221
TABLE 211 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 222
TABLE 212 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 222
TABLE 213 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 223
TABLE 214 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 223
TABLE 215 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 223
TABLE 216 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 224
TABLE 217 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 224
TABLE 218 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 224
TABLE 219 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 225
9.2.1 US 225
9.2.1.1 Rising prevalence of cardiovascular and neurological disorders to drive market 225
TABLE 220 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 227
TABLE 221 US: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 227
TABLE 222 US: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 228
TABLE 223 US: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 228
TABLE 224 US: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 229
TABLE 225 US: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 229
TABLE 226 US: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 230
TABLE 227 US: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 230
TABLE 228 US: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 230
TABLE 229 US: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 231
TABLE 230 US: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 231
TABLE 231 US: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 231
9.2.2 CANADA 232
9.2.2.1 Rising healthcare expenditure and increasing prevalence of chronic diseases to drive demand 232
TABLE 232 NEUROLOGICAL CONDITIONS PREVALENT IN CANADA, 2016–2031 232
TABLE 233 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 233
TABLE 234 CANADA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 234
TABLE 235 CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 234
TABLE 236 CANADA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 235
TABLE 237 CANADA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 235
TABLE 238 CANADA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 236
TABLE 239 CANADA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 236
TABLE 240 CANADA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 236
TABLE 241 CANADA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 237
TABLE 242 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 237
TABLE 243 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 237
TABLE 244 CANADA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 238
9.2.3 NORTH AMERICA: RECESSION IMPACT 238
9.3 EUROPE 238
TABLE 245 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 239
TABLE 246 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 239
TABLE 247 EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 240
TABLE 248 EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 240
TABLE 249 EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 241
TABLE 250 EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 241
TABLE 251 EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 242
TABLE 252 EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 242
TABLE 253 EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 242
TABLE 254 EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 243
TABLE 255 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 243
TABLE 256 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 243
TABLE 257 EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 244
9.3.1 GERMANY 244
9.3.1.1 Presence of favorable reimbursement policies to drive market 244
TABLE 258 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 245
TABLE 259 GERMANY: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 245
TABLE 260 GERMANY: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 246
TABLE 261 GERMANY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 246
TABLE 262 GERMANY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 247
TABLE 263 GERMANY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 247
TABLE 264 GERMANY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 248
TABLE 265 GERMANY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 248
TABLE 266 GERMANY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 248
TABLE 267 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 249
TABLE 268 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 249
TABLE 269 GERMANY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 249
9.3.2 UK 250
9.3.2.1 Rising support from government and private organizations to fuel market growth 250
TABLE 270 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 251
TABLE 271 UK: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 251
TABLE 272 UK: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 252
TABLE 273 UK: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 252
TABLE 274 UK: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 253
TABLE 275 UK: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 253
TABLE 276 UK: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 254
TABLE 277 UK: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 254
TABLE 278 UK: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 254
TABLE 279 UK: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 255
TABLE 280 UK: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 255
TABLE 281 UK: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 255
9.3.3 FRANCE 256
9.3.3.1 Promising healthcare reforms to drive market 256
TABLE 282 FRANCE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 256
TABLE 283 FRANCE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 257
TABLE 284 FRANCE: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 257
TABLE 285 FRANCE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 258
TABLE 286 FRANCE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 258
TABLE 287 FRANCE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 259
TABLE 288 FRANCE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 259
TABLE 289 FRANCE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 259
TABLE 290 FRANCE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 260
TABLE 291 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 260
TABLE 292 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 260
TABLE 293 FRANCE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 261
9.3.4 ITALY 261
9.3.4.1 Easy access to healthcare services to create lucrative opportunities for market growth 261
TABLE 294 ITALY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 262
TABLE 295 ITALY: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 263
TABLE 296 ITALY: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 263
TABLE 297 ITALY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 264
TABLE 298 ITALY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 264
TABLE 299 ITALY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 265
TABLE 300 ITALY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 265
TABLE 301 ITALY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 265
TABLE 302 ITALY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 266
TABLE 303 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 266
TABLE 304 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 266
TABLE 305 ITALY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 267
9.3.5 SPAIN 267
9.3.5.1 Increasing number of conferences and awareness programs to support market growth 267
TABLE 306 SPAIN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 268
TABLE 307 SPAIN: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 268
TABLE 308 SPAIN: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 269
TABLE 309 SPAIN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 269
TABLE 310 SPAIN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 269
TABLE 311 SPAIN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 270
TABLE 312 SPAIN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 270
TABLE 313 SPAIN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 270
TABLE 314 SPAIN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 271
TABLE 315 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 271
TABLE 316 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 271
TABLE 317 SPAIN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 272
9.3.6 REST OF EUROPE 272
TABLE 318 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 273
TABLE 319 REST OF EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 273
TABLE 320 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 274
TABLE 321 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 274
TABLE 322 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 275
TABLE 323 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 275
TABLE 324 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 276
TABLE 325 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 276
TABLE 326 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 276
TABLE 327 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 277
TABLE 328 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 277
TABLE 329 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 278
9.3.7 EUROPE: RECESSION IMPACT 278
9.4 ASIA PACIFIC 278
FIGURE 30 ASIA PACIFIC: ELECTROCEUTICALS MARKET SNAPSHOT 279
TABLE 330 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 280
TABLE 331 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 280
TABLE 332 ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 281
TABLE 333 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 281
TABLE 334 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 282
TABLE 335 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 282
TABLE 336 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 283
TABLE 337 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 283
TABLE 338 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 283
TABLE 339 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 284
TABLE 340 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 284
TABLE 341 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 284
TABLE 342 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 285
9.4.1 JAPAN 285
9.4.1.1 Increasing prevalence of cardiovascular and neurological disorders to drive demand 285
TABLE 343 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 286
TABLE 344 JAPAN: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 287
TABLE 345 JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 287
TABLE 346 JAPAN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 288
TABLE 347 JAPAN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 288
TABLE 348 JAPAN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 289
TABLE 349 JAPAN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 289
TABLE 350 JAPAN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 290
TABLE 351 JAPAN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 290
TABLE 352 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 290
TABLE 353 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 291
TABLE 354 JAPAN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 291
9.4.2 CHINA 291
9.4.2.1 Rising geriatric population to support market growth 291
TABLE 355 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 292
TABLE 356 CHINA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 293
TABLE 357 CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 293
TABLE 358 CHINA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 294
TABLE 359 CHINA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 294
TABLE 360 CHINA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 295
TABLE 361 CHINA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 295
TABLE 362 CHINA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 296
TABLE 363 CHINA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 296
TABLE 364 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 296
TABLE 365 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 297
TABLE 366 CHINA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 297
9.4.3 INDIA 297
9.4.3.1 Developments in healthcare structure to propel market 297
TABLE 367 INDIA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 298
TABLE 368 INDIA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 299
TABLE 369 INDIA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 299
TABLE 370 INDIA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 300
TABLE 371 INDIA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 300
TABLE 372 INDIA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 301
TABLE 373 INDIA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 301
TABLE 374 INDIA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 301
TABLE 375 INDIA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 302
TABLE 376 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 302
TABLE 377 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 302
TABLE 378 INDIA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 303
9.4.4 REST OF ASIA PACIFIC 303
TABLE 379 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 304
TABLE 380 REST OF ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 304
TABLE 381 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 305
TABLE 382 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 305
TABLE 383 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 306
TABLE 384 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 306
TABLE 385 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 307
TABLE 386 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 307
TABLE 387 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 307
TABLE 388 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 308
TABLE 389 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 308
TABLE 390 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 308
9.4.5 ASIA PACIFIC: RECESSION IMPACT 309
9.5 LATIN AMERICA 309
9.5.1 RAPIDLY GROWING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH 309
TABLE 391 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 310
TABLE 392 LATIN AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 311
TABLE 393 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 311
TABLE 394 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 312
TABLE 395 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 312
TABLE 396 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 313
TABLE 397 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 313
TABLE 398 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 313
TABLE 399 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 314
TABLE 400 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 314
TABLE 401 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 314
TABLE 402 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 315
9.5.2 LATIN AMERICA: RECESSION IMPACT 315
9.6 MIDDLE EAST & AFRICA 315
TABLE 403 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY REGION, 2021–2029 (USD MILLION) 316
TABLE 404 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 316
TABLE 405 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 317
TABLE 406 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 317
TABLE 407 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION) 318
TABLE 408 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 318
TABLE 409 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 319
TABLE 410 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 319
TABLE 411 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 319
TABLE 412 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 320
TABLE 413 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 320
TABLE 414 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 320
TABLE 415 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION) 321
9.6.1 GCC COUNTRIES 321
9.6.1.1 Advances in healthcare sector to support market growth 321
TABLE 416 GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 322
TABLE 417 GCC COUNTRIES: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 322
TABLE 418 GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 323
9.6.2 REST OF MIDDLE EAST & AFRICA 323
TABLE 419 REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 324
TABLE 420 REST OF MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 324
TABLE 421 REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 325
9.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT 325
10 COMPETITIVE LANDSCAPE 326
10.1 OVERVIEW 326
10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN 326
TABLE 422 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 326
10.3 REVENUE ANALYSIS 328
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROCEUTICALS MARKET 328
10.4 MARKET SHARE ANALYSIS 328
TABLE 423 ELECTROCEUTICALS MARKET: DEGREE OF COMPETITION 329
10.5 BRAND/PRODUCT COMPARISON 330
FIGURE 32 ELECTROCEUTICALS MARKET: BRAND COMPARISON, BY KEY PLAYER 330
10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS 330
10.6.1 STARS 330
10.6.2 EMERGING LEADERS 330
10.6.3 PERVASIVE PLAYERS 331
10.6.4 PARTICIPANTS 331
FIGURE 33 ELECTROCEUTICALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022 331
10.7 COMPANY FOOTPRINT 332
TABLE 424 PRODUCT FOOTPRINT 332
TABLE 425 REGIONAL FOOTPRINT 333
TABLE 426 OVERALL COMPANY FOOTPRINT 334
10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES 334
10.8.1 PROGRESSIVE COMPANIES 334
10.8.2 STARTING BLOCKS 334
10.8.3 RESPONSIVE COMPANIES 335
10.8.4 DYNAMIC COMPANIES 335
FIGURE 34 ELECTROCEUTICALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/ SMES), 2022 335
10.9 COMPETITIVE BENCHMARKING 336
TABLE 427 ELECTROCEUTICALS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 336
TABLE 428 PRODUCT FOOTPRINT (STARTUPS/SMES) 337
TABLE 429 REGIONAL FOOTPRINT (STARTUPS/SMES) 337
TABLE 430 OVERALL COMPANY FOOTPRINT (STARTUPS/SMES) 338
10.10 COMPETITIVE SCENARIO 338
10.10.1 PRODUCT LAUNCHES & APPROVALS 338
TABLE 431 PRODUCT LAUNCHES & APPROVALS 338
10.10.2 DEALS 340
TABLE 432 DEALS 340

11 COMPANY PROFILES 341
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 KEY PLAYERS 341
11.1.1 MEDTRONIC 341
TABLE 433 MEDTRONIC: BUSINESS OVERVIEW 341
FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2023) 342
11.1.2 BOSTON SCIENTIFIC CORPORATION 347
TABLE 434 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 347
FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 348
11.1.3 ABBOTT 352
TABLE 435 ABBOTT: BUSINESS OVERVIEW 352
FIGURE 37 ABBOTT: COMPANY SNAPSHOT (2022) 353
11.1.4 LIVANOVA PLC 357
TABLE 436 LIVANOVA PLC: BUSINESS OVERVIEW 357
FIGURE 38 LIVANOVA PLC: COMPANY SNAPSHOT (2022) 358
11.1.5 COCHLEAR LTD. 360
TABLE 437 COCHLEAR LTD.: BUSINESS OVERVIEW 360
FIGURE 39 COCHLEAR LTD.: COMPANY SNAPSHOT (2023) 361
11.1.6 MICROPORT SCIENTIFIC CORPORATION 363
TABLE 438 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 363
FIGURE 40 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 364
11.1.7 SONOVA 367
TABLE 439 SONOVA: BUSINESS OVERVIEW 367
FIGURE 41 SONOVA GROUP: COMPANY SNAPSHOT (2022) 368
11.1.8 NEVRO CORP. 370
TABLE 440 NEVRO CORP.: BUSINESS OVERVIEW 370
FIGURE 42 NEVRO CORP.: COMPANY SNAPSHOT (2022) 370
11.1.9 AXONICS, INC. 372
TABLE 441 AXONICS, INC.: BUSINESS OVERVIEW 372
FIGURE 43 AXONICS INC.: COMPANY SNAPSHOT (2022) 372
11.1.10 NEURONETICS 374
TABLE 442 NEURONETICS: BUSINESS OVERVIEW 374
FIGURE 44 NEURONETICS: COMPANY SNAPSHOT (2022) 375
11.1.11 ELECTROCORE, INC. 377
TABLE 443 ELECTROCORE, INC.: BUSINESS OVERVIEW 377
FIGURE 45 ELECTROCORE, INC.: COMPANY SNAPSHOT (2022) 377
11.1.12 NEUROPACE, INC. 379
TABLE 444 NEUROPACE, INC.: BUSINESS OVERVIEW 379
FIGURE 46 NEUROPACE, INC.: COMPANY SNAPSHOT (2022) 379
11.2 OTHER PLAYERS 381
11.2.1 BIOTRONIK 381
TABLE 445 BIOTRONIK: COMPANY OVERVIEW 381
11.2.2 MEDICO S.R.L. 383
TABLE 446 MEDICO S.R.L.: COMPANY OVERVIEW 383
11.2.3 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD. 384
TABLE 447 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 384
11.2.4 MED-EL 385
TABLE 448 MED-EL: COMPANY OVERVIEW 385
11.2.5 ALEVA NEUROTHERAPEUTICS 385
TABLE 449 ALEVA NEUROTHERAPEUTICS: COMPANY OVERVIEW 385
11.2.6 NEUROSIGMA, INC. 386
TABLE 450 NEUROSIGMA, INC.: COMPANY OVERVIEW 386
11.2.7 BIOWAVE CORPORATION 387
TABLE 451 BIOWAVE CORPORATION: COMPANY OVERVIEW 387
11.2.8 SOTERIX MEDICAL INC. 388
TABLE 452 SOTERIX MEDICAL INC.: COMPANY OVERVIEW 388
11.2.9 BIOINDUCTION (AMBER THERAPEUTICS) 388
TABLE 453 BIOINDUCTION (AMBER THERAPEUTICS): COMPANY OVERVIEW 388
11.2.10 GIMER MEDICAL 389
TABLE 454 GIMER MEDICAL: COMPANY OVERVIEW 389
11.2.11 CEFALY 389
TABLE 455 CEFALY: COMPANY OVERVIEW 389
11.2.12 BIOCONTROL MEDICAL 390
TABLE 456 BIOCONTROL MEDICAL: COMPANY OVERVIEW 390
11.2.13 TVNS HEALTH GMBH 390
TABLE 457 TVNS HEALTH GMBH: COMPANY OVERVIEW 390
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX 391
12.1 DISCUSSION GUIDE 391
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 396
12.3 CUSTOMIZATION OPTIONS 398
12.4 RELATED REPORTS 399
12.5 AUTHOR DETAILS 400

*** 電気治療/生体電気医療の世界市場に関するよくある質問(FAQ) ***

・電気治療/生体電気医療の世界市場規模は?
→MarketsandMarkets社は2023年の電気治療/生体電気医療の世界市場規模を239億米ドルと推定しています。

・電気治療/生体電気医療の世界市場予測は?
→MarketsandMarkets社は2029年の電気治療/生体電気医療の世界市場規模を336億米ドルと予測しています。

・電気治療/生体電気医療市場の成長率は?
→MarketsandMarkets社は電気治療/生体電気医療の世界市場が2023年~2029年に年平均7%成長すると展望しています。

・世界の電気治療/生体電気医療市場における主要プレイヤーは?
→「Medtronic plc (アイルランド)、Boston Scientific Corporation(米国)、Abbott Laboratories, Inc.(米国)、Cochlear Ltd.(オーストラリア)、LivaNova PLC(英国)、MicroPort Scientific Corporation(中国)、Sonova Group (Switzerland)、Nevro Corp.(米国)、Axonics Modulation Technologies, Inc.(米国)、Neuronetics, Inc.(米国)など ...」を電気治療/生体電気医療市場のグローバル主要プレイヤーとして判断しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MD4358-24 )"電気治療/生体電気医療の世界市場予測(~2029):製品別、種類別、用途別" (英文:Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) - Global Forecast to 2029)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。